Coston McIsaac & Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
117
| – | – | ﹤0.01% | 491 |
|
|
2025
Q1 | $13K | Buy |
117
+1
| +0.9% | +$111 | ﹤0.01% | 462 |
|
|
2024
Q4 | $10K | Buy |
116
+1
| +0.9% | +$86 | ﹤0.01% | 479 |
|
|
2024
Q3 | $9 | Buy |
115
+1
| +0.9% | – | ﹤0.01% | 514 |
|
|
2024
Q2 | $7K | Buy |
114
+2
| +2% | +$123 | ﹤0.01% | 519 |
|
|
2024
Q1 | $8K | Buy |
112
+1
| +0.9% | +$71 | ﹤0.01% | 507 |
|
|
2023
Q4 | $9K | Buy |
111
+1
| +0.9% | +$81 | ﹤0.01% | 485 |
|
|
2023
Q3 | $8K | Buy |
110
+1
| +0.9% | +$73 | ﹤0.01% | 495 |
|
|
2023
Q2 | $8K | Buy |
109
+1
| +0.9% | +$73 | ﹤0.01% | 532 |
|
|
2023
Q1 | $9K | Buy |
108
+1
| +0.9% | +$83 | ﹤0.01% | 500 |
|
|
2022
Q4 | $9 | Buy |
107
+1
| +0.9% | – | ﹤0.01% | 510 |
|
|
2022
Q3 | $6K | Buy |
106
+1
| +1% | +$57 | ﹤0.01% | 483 |
|
|
2022
Q2 | $7K | Buy |
+105
| New | +$7K | ﹤0.01% | 312 |
|